Dr Victoria Lynn Lim, MD | |
5625 Poplar Ave, Memphis, TN 38119-3816 | |
(901) 761-1220 | |
(901) 763-4332 |
Full Name | Dr Victoria Lynn Lim |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Experience | 30 Years |
Location | 5625 Poplar Ave, Memphis, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225049141 | NPI | - | NPPES |
00121592 | Medicaid | MS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | MD0000031541 (Tennessee) | Secondary |
207Y00000X | Otolaryngology | 16412 (Mississippi) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Shea Clinic | 3971525635 | 6 |
News Archive
Terrorism, climate change and now a pandemic - worries and fears shape the everyday lives of many people. The latest issue of the Science Magazine BfR2GO from the German Federal Institute for Risk Assessment (BfR) is dedicated to fear, while at the same time embarking on a search for confidence. Scientists from many spheres have their chance to speak and categorize the concepts in a clear way.
Ventas, Inc. ("Ventas" or the "Company") said today that it closed on a commitment for $50 million of additional credit capacity under the Company's Revolving Credit Facilities to mature in 2012.
Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products for approximately $540 million in cash. Perrigo expects to receive a significant tax benefit as a result of the acquisition of Paddock's assets. The net present value of this tax benefit is estimated to be $95 million.
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
› Verified 7 days ago
Entity Name | Shea Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568427128 PECOS PAC ID: 3971525635 Enrollment ID: O20090429000705 |
News Archive
Terrorism, climate change and now a pandemic - worries and fears shape the everyday lives of many people. The latest issue of the Science Magazine BfR2GO from the German Federal Institute for Risk Assessment (BfR) is dedicated to fear, while at the same time embarking on a search for confidence. Scientists from many spheres have their chance to speak and categorize the concepts in a clear way.
Ventas, Inc. ("Ventas" or the "Company") said today that it closed on a commitment for $50 million of additional credit capacity under the Company's Revolving Credit Facilities to mature in 2012.
Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products for approximately $540 million in cash. Perrigo expects to receive a significant tax benefit as a result of the acquisition of Paddock's assets. The net present value of this tax benefit is estimated to be $95 million.
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Victoria Lynn Lim, MD 5960 Getwell Road, Suite 212d, Southaven, MS 38672-7320 Ph: (662) 895-6455 | Dr Victoria Lynn Lim, MD 5625 Poplar Ave, Memphis, TN 38119-3816 Ph: (901) 761-1220 |
News Archive
Terrorism, climate change and now a pandemic - worries and fears shape the everyday lives of many people. The latest issue of the Science Magazine BfR2GO from the German Federal Institute for Risk Assessment (BfR) is dedicated to fear, while at the same time embarking on a search for confidence. Scientists from many spheres have their chance to speak and categorize the concepts in a clear way.
Ventas, Inc. ("Ventas" or the "Company") said today that it closed on a commitment for $50 million of additional credit capacity under the Company's Revolving Credit Facilities to mature in 2012.
Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products for approximately $540 million in cash. Perrigo expects to receive a significant tax benefit as a result of the acquisition of Paddock's assets. The net present value of this tax benefit is estimated to be $95 million.
The U.S. Food and Drug Administration today approved Erleada (apalutamide) for the treatment of patients with prostate cancer that has not spread (non-metastatic), but that continues to grow despite treatment with hormone therapy (castration-resistant). This is the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer.
› Verified 7 days ago
Samuel Henry Smith, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: Universuty Of Tennessee, 920 Madison Avenue Suite 447, Memphis, TN 38163 Phone: 901-448-5885 | |
Dr. Anthony Sheyn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 51 N Dunlap St, Suite G10, Memphis, TN 38105 Phone: 901-287-7337 Fax: 901-266-6620 | |
Dr. Christopher James Hall, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5625 Poplar Ave, Memphis, TN 38119 Phone: 901-761-1220 Fax: 901-763-4332 | |
Anas Eid, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1068 Cresthaven Rd Ste 250, Memphis, TN 38119 Phone: 858-337-0500 | |
Robert James Yawn, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1325 Eastmoreland Ave Ste 260, Memphis, TN 38104 Phone: 901-272-6051 Fax: 901-266-6443 | |
Dr. Phillip R Langsdon, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1910 Nonconnah Blvd, Suite 120, Memphis, TN 38132 Phone: 901-448-2300 Fax: 901-448-6657 |